Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1243.35
8.75
(0.71%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories reports 75% rise in Q3 consolidated net profit
>>
Dr.Reddy's Laboratories informs about disclosure
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy's Lab - Quaterly Results
>>
Dr. Reddy’s completes full set of clinical studies of rituximab biosimilar for filing in U.S., Europe
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr Reddy's reduces price of cardiovascular drug ‘Cidmus’
>>
Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products
>>
Dr. Reddy's inks pact with Theranica
<<
<
25
26
27
...143
>
>>